C17ORF108-HAP1 Fusion FISH Probe
The C17ORF108-HAP1 Fusion FISH Probe is used to confirm a fusion of the C17ORF108 and HAP1 genes. The fusion of the C17ORF108 and HAP1 genes has been associated with Stomach Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| C17ORF108-HAP1-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-RERE | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-REOR | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-REGO | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-REGR | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-OROR | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-GORE | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-GROR | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| C17ORF108-HAP1-20-AQAQ | 20 (40 μL) | 200 μL |
|
HAP1 Gene Summary
Huntington's disease (HD), a neurodegenerative disorder characterized by loss of striatal neurons, is caused by an expansion of a polyglutamine tract in the HD protein huntingtin. This gene encodes a protein that interacts with huntingtin, with two cytoskeletal proteins (dynactin and pericentriolar autoantigen protein 1), and with a hepatocyte growth factor-regulated tyrosine kinase substrate. The interactions with cytoskeletal proteins and a kinase substrate suggest a role for this protein in vesicular trafficking or organelle transport. Several alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Gene Name: Huntingtin Associated Protein 1
Chromosome: CHR17: 39878890 -39890898
Locus: 17q21.2
Gene Diseases
The C17ORF108 HAP1 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Stomach Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|